老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

4D Molecular Therapeutics

3.06
+0.15005.15%
盘后：3.100.0400+1.31%19:58 EDT
成交量：37.79万
成交额：113.89万
市值：1.42亿
市盈率：-1.03
高：3.07
开：2.90
低：2.89
收：2.91
数据加载中...
总览公司新闻公告
2021/05/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/13

重要事件披露

8-K - Current report
2021/03/25

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/25

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/25

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/23

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/21

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/15

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/12/15

重要事件披露

8-K - Current report
2020/12/10

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/12/08

SEC问询函

CORRESP [Cover] - Correspondence
2020/12/08

SEC问询函

CORRESP [Cover] - Correspondence
2020/12/07

SEC问询函

CORRESP [Cover] - Correspondence
2020/12/07

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
更多